OXFORD ASSET MANAGEMENT LLP - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 70 filers reported holding IMMUNE DESIGN CORP in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
OXFORD ASSET MANAGEMENT LLP ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q1 2019$1,584,000
+794.9%
270,803
+98.4%
0.04%
+600.0%
Q4 2018$177,000
-47.3%
136,468
+325.9%
0.01%
-16.7%
Q3 2017$336,000
-20.8%
32,039
-26.4%
0.01%
-25.0%
Q2 2017$424,000
-35.9%
43,529
-55.2%
0.01%
-50.0%
Q1 2017$661,000
+17.0%
97,228
-5.3%
0.02%
-20.0%
Q4 2016$565,000
+19.2%
102,692
+76.8%
0.02%
+25.0%
Q2 2016$474,000
-50.1%
58,083
-20.5%
0.02%
-40.7%
Q1 2016$950,000
-18.5%
73,054
+29.9%
0.03%0.0%
Q4 2015$1,166,00056,2480.03%
Other shareholders
IMMUNE DESIGN CORP shareholders Q1 2019
NameSharesValueWeighting ↓
ProQuest Associates IV LLC 1,962,720$16,016,0006.52%
Abingworth LLP 197,300$1,610,0001.69%
NEXTHERA CAPITAL LP 85,138$695,0000.60%
Cormorant Asset Management, LP 432,990$3,533,0000.50%
SPHERA FUNDS MANAGEMENT LTD. 153,000$1,248,0000.32%
TFS CAPITAL LLC 102,685$838,0000.15%
RS INVESTMENT MANAGEMENT CO LLC 1,227,595$10,017,0000.10%
Eventide Asset Management 180,000$1,469,0000.09%
Focused Wealth Management, Inc 15,868$129,0000.06%
Spark Investment Management LLC 77,500$632,0000.06%
View complete list of IMMUNE DESIGN CORP shareholders